Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12
pubmed:dateCreated
1993-2-5
pubmed:abstractText
We have investigated the influence of diabetes mellitus including the presence of late complications of the pulmonary system. To check this relationship 31 Type 1 (insulin-dependent) diabetic patients (mean age 30.6 +/- 5.32 years, mean duration of diabetes 12.9 +/- 5.05 years) were admitted into the trial and compared with 18 control subjects. Pulmonary function tests were measured including spirometric parameters, diffusing capacity, specific diffusing capacity and dynamic compliance measured at 20 and 60 breaths per min. No disturbance of the spirometric parameters was observed in the diabetic patients. Diffusing capacity in the diabetic patients with complications was significantly lower than in both the diabetic patients without complications and the control group (81.2 +/- 16.2%, 104 +/- 13.7%, 99.3 +/- 2.8%; p < 0.001, p < 0.005 respectively). Specific diffusing capacity was significantly lower in the diabetic patients than in the control subjects (80.3 +/- 13.1% vs 89.4 +/- 12.9%; p < 0.05). In the group with late complications specific diffusing capacity was lower than in the group without complications (69.7 +/- 9.17%; 87.2 +/- 10.7%, respectively; p < 0.001). Dynamic compliance at 20 breaths per min in diabetic patients was 84.06 +/- 17.08% vs 95.2 +/- 11.59% in the control subjects (p < 0.05). It was particularly low in the group with late complications 80.6 +/- 13.2% and patients with metabolic poor control, 80.3 +/- 12.02% (both p < 0.005 vs the control group). Dynamic compliance at 60 breaths per min was 60.1 +/- 15.0% as compared to 83.2 +/- 13.3% in the control group (p < 0.001).(ABSTRACT TRUNCATED AT 250 WORDS)
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0012-186X
pubmed:author
pubmed:issnType
Print
pubmed:volume
35
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1173-6
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed-meshheading:1478371-Adult, pubmed-meshheading:1478371-Biological Markers, pubmed-meshheading:1478371-Carbon Dioxide, pubmed-meshheading:1478371-Diabetes Mellitus, Type 1, pubmed-meshheading:1478371-Diabetic Nephropathies, pubmed-meshheading:1478371-Diabetic Neuropathies, pubmed-meshheading:1478371-Diabetic Retinopathy, pubmed-meshheading:1478371-Female, pubmed-meshheading:1478371-Forced Expiratory Flow Rates, pubmed-meshheading:1478371-Fructosamine, pubmed-meshheading:1478371-Hemoglobin A, Glycosylated, pubmed-meshheading:1478371-Hexosamines, pubmed-meshheading:1478371-Humans, pubmed-meshheading:1478371-Lung, pubmed-meshheading:1478371-Male, pubmed-meshheading:1478371-Reference Values, pubmed-meshheading:1478371-Respiratory Function Tests, pubmed-meshheading:1478371-Spirometry, pubmed-meshheading:1478371-Vital Capacity
pubmed:year
1992
pubmed:articleTitle
Pulmonary complications of type 1 (insulin-dependent) diabetic patients.
pubmed:affiliation
Department of Internal and Occupational Diseases, Silesian Academy of Medicine, Zabrze, Poland.
pubmed:publicationType
Journal Article